Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Statement | 23 August 2022 Diagnostics Principles for Access to Multi-disease Molecular Diagnostics Technical brief | 01 August 2022 Intellectual property and trade The importance of pre-grant patent oppositions in increasing access to medical products Photograph by Tommy Trenchard Press release Press release | 28 July 2022 HIV/AIDS Following WHO recommendation, access to new game-changing HIV prevention drug needs to be accelerated 4 min Video Video | 28 July 2022 COVID-19 #ShareTheTech - why pharma must share the mRNA vaccine technology Issue brief Issue brief | 25 July 2022 HIV/AIDS Cabotegravir: What are we waiting for? Letter | 19 July 2022 HIV/AIDS CSO letter to ViiV calling for access to HIV PrEP drug CAB-LA Photograph by Nicolas Guyonnet Press release Press release | 24 June 2022 COVID-19 MSF responds to BioNTech announcement that it will set up first “BioNTainers” by end of 2022 3 min Newsletter Newsletter | 24 June 2022 COVID-19 WTO adopts inadequate text, not a real Waiver on COVID monopolies Load More
Technical brief | 01 August 2022 Intellectual property and trade The importance of pre-grant patent oppositions in increasing access to medical products
Photograph by Tommy Trenchard Press release Press release | 28 July 2022 HIV/AIDS Following WHO recommendation, access to new game-changing HIV prevention drug needs to be accelerated 4 min
Video Video | 28 July 2022 COVID-19 #ShareTheTech - why pharma must share the mRNA vaccine technology
Photograph by Nicolas Guyonnet Press release Press release | 24 June 2022 COVID-19 MSF responds to BioNTech announcement that it will set up first “BioNTainers” by end of 2022 3 min
Newsletter Newsletter | 24 June 2022 COVID-19 WTO adopts inadequate text, not a real Waiver on COVID monopolies
